Mitchell S. Cairo mostly deals with Internal medicine, Surgery, Transplantation, Oncology and Lymphoma. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. His Surgery research is multidisciplinary, incorporating elements of Lower risk and Intensive care medicine.
His research in Transplantation intersects with topics in Leukemia, Immunology, Cord blood and Histocompatibility. His Oncology study combines topics in areas such as Lymphoblastic lymphoma, Hematology, Diffuse large B-cell lymphoma, Anaplastic large-cell lymphoma and Prospective cohort study. His work deals with themes such as Young adult, Cancer and Hazard ratio, which intersect with Lymphoma.
Mitchell S. Cairo focuses on Internal medicine, Transplantation, Immunology, Oncology and Lymphoma. He has included themes like Gastroenterology and Surgery in his Internal medicine study. Within one scientific family, Mitchell S. Cairo focuses on topics pertaining to Disease under Transplantation, and may sometimes address concerns connected to Cell.
His Immunology research includes themes of Molecular biology and Cytotoxic T cell. His Oncology research is multidisciplinary, relying on both Young adult, Hematology, Hodgkin lymphoma, Myeloid leukemia and Acute leukemia. His Lymphoma research includes themes of Cancer and Cancer research.
Mitchell S. Cairo mainly focuses on Internal medicine, Transplantation, Oncology, Cancer research and Lymphoma. Myeloid is closely connected to Gastroenterology in his research, which is encompassed under the umbrella topic of Internal medicine. His Transplantation research is multidisciplinary, incorporating elements of Leukemia, Stem cell, Disease and Hazard ratio.
Mitchell S. Cairo studied Oncology and Fludarabine that intersect with Busulfan and Total body irradiation. Mitchell S. Cairo interconnects Cytotoxic T cell, Granzyme B, Interleukin 15, Rituximab and CD20 in the investigation of issues within Cancer research. The Rituximab study combines topics in areas such as Chemotherapy and Antibody-dependent cell-mediated cytotoxicity.
His scientific interests lie mostly in Internal medicine, Oncology, Lymphoma, Transplantation and Cancer research. As part of his studies on Internal medicine, he often connects relevant subjects like Gastroenterology. His Oncology research is multidisciplinary, incorporating perspectives in Melphalan, Rituximab, Chemoimmunotherapy, Diffuse large B-cell lymphoma and Follicular lymphoma.
His studies in Lymphoma integrate themes in fields like Young adult, Pediatrics and Chemotherapy. His Transplantation research incorporates elements of Cytarabine, Leukemia and Sibling. His research integrates issues of Cell growth, Carcinogenesis, NKG2D, Phosphorylation and Immunotherapy in his study of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Hematopoietic Engraftment and Survival in Adult Recipients of Umbilical-Cord Blood from Unrelated Donors
Mary J. Laughlin;Juliet Barker;Barbara Bambach;Omer N. Koc.
The New England Journal of Medicine (2001)
Tumour lysis syndrome: new therapeutic strategies and classification
Mitchell S. Cairo;Michael Bishop.
British Journal of Haematology (2004)
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome
Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg.
Guidelines for the Management of Pediatric and Adult Tumor Lysis Syndrome: An Evidence-Based Review
Bertrand Coiffier;Arnold Altman;Ching-Hon Pui;Anas Younes.
Journal of Clinical Oncology (2008)
A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis
Stanton C. Goldman;John S. Holcenberg;Jerry Z. Finklestein;Raymond Hutchinson.
Risk factors for acute GVHD and survival after hematopoietic cell transplantation.
Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients
Catherine Patte;Anne Auperin;Mary Gerrard;Jean Michon.
Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus.
Mitchell S. Cairo;Bertrand Coiffier;Alfred Reiter;Anas Younes.
British Journal of Haematology (2010)
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents
Mitchell S. Cairo;Mary Gerrard;Richard Sposto;Anne Auperin.
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling
Jon J. Van Rood;Fausto R. Loberiza;Mei Jie Zhang;Machteld Oudshoorn.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: